MarketPulse

Pivotal Study

9 articles
GlobeNewswire Inc.GlobeNewswire Inc.··Rosen Law Firm

Securities Class Action Filed Against uniQure Over FDA Approval Misrepresentations

Securities class action filed against uniQure alleging FDA approval misrepresentations. April 13, 2026 deadline for lead plaintiff claims.
QUREsecurities class actionFDA approval
BenzingaBenzinga··Djs Law Group

Gene Therapy Firm uniQure Faces Securities Class Action Over FDA Study Claims

uniQure faces class action lawsuit alleging misleading statements about pivotal study design and FDA approval prospects. Shareholders have until April 13, 2026 to join.
QUREsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Bronstein, Gewirtz & Grossman Llc

uniQure Hit by Class Action Over FDA Approval Claims and BLA Timeline Delays

Class action lawsuit filed against $UQRR alleging materially false statements about FDA approval and BLA timeline delays. Investors urged to join by April 13, 2026 deadline.
QUREsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Levi & Korsinsky, Llp

uniQure Faces Securities Lawsuit Over Alleged FDA Approval Misstatements

Levi & Korsinsky sued $QURE over false FDA statements. Investors who lost money Sept-Oct 2025 can claim damages by April 13, 2026.
QUREsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Rosen Law Firm

uniQure Faces Securities Lawsuit Over Huntington's Study Design Misrepresentation

uniQure faces securities lawsuit for allegedly misrepresenting Huntington's study design approval and downplaying BLA delays. Investors must act by April 13, 2026.
QUREsecurities class actionFDA approval
GlobeNewswire Inc.GlobeNewswire Inc.··Holzer & Holzer, Llc

uniQure Securities Lawsuit: Investors Face April 2026 Deadline Amid FDA Approval Allegations

uniQure faces shareholder lawsuit alleging false statements on FDA approval and study design. Lead plaintiff deadline: April 13, 2026.
QUREshareholder lawsuitsecurities class action
GlobeNewswire Inc.GlobeNewswire Inc.··Bragar Eagel & Squire, P.C.

Legal Action Filed Against uniQure Over FDA Approval Statements

Class action lawsuit filed against uniQure for allegedly making false statements about FDA approval status and BLA submission timelines, misleading investors.
QUREsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Bronstein, Gewirtz & Grossman Llc

uniQure Faces Class Action Over FDA Study Claims and BLA Timeline Disclosures

uniQure faces class action lawsuit alleging misleading statements about FDA study status and BLA timeline delays. Investors who purchased shares Sept-Oct 2025 may be eligible to claim.
QUREsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Bronstein, Gewirtz & Grossman Llc

Class Action Lawsuit Filed Against uniQure Over FDA Approval Disclosures

uniQure faces class action lawsuit alleging misleading FDA approval statements and understated BLA timeline risks. Investors who purchased securities between September-October 2025 may be eligible to participate.
QUREsecurities fraudclass action lawsuit